Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study (Q36560252)
Jump to navigation
Jump to search
scientific article published on October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study |
scientific article published on October 2012 |
Statements
1 reference
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study (English)
1 reference
Maximilian von Eynatten
1 reference
Janet B McGill
1 reference
Lance Sloan
1 reference
Jennifer Newman
1 reference
Sanjay Patel
1 reference
Christophe Sauce
1 reference
Hans-Juergen Woerle
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference